Split History
ETFs Holding VBIV »    VBIV Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
VBI Vaccines is a biopharmaceutical company. Co. is developing the prevention and treatment of hepatitis B, with trivalent hepatitis B vaccine, Sci-B-Vac, which is approved for use and available in Israel; and with VBI-2601 (BRII-179), an immunotherapeutic candidate in development for a functional cure for chronic hepatitis B. Co.'s enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. Co.'s primary eVLP program candidates include a glioblastoma vaccine immunotherapeutic candidate, VBI-1901, and a prophylactic cytomegalovirus vaccine candidate, VBI-1501. According to our VBIV split history records, VBI Vaccines has had 1 split.
VBIV split history picture
VBI Vaccines (VBIV) has 1 split in our VBIV split history database. The split for VBIV took place on July 29, 2014. This was a 1 for 5 reverse split, meaning for each 5 shares of VBIV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as VBI Vaccines conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the VBIV split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into VBI Vaccines shares, starting with a $10,000 purchase of VBIV, presented on a split-history-adjusted basis factoring in the complete VBIV split history. VBIV split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 04/14/2011
End date: 04/13/2021
Start price/share: $6.15
End price/share: $2.85
Starting shares: 1,626.02
Ending shares: 1,699.93
Dividends reinvested/share: $0.25
Total return: -51.55%
Average Annual Total Return: -6.99%
Starting investment: $10,000.00
Ending investment: $4,843.11
Years: 10.01
Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/14/2011
End date: 04/13/2021
Start price/share: $6.15
End price/share: $2.85
Dividends collected/share: $0.25
Total return: -49.59%
Average Annual Total Return: -6.62%
Starting investment: $10,000.00
Ending investment: $5,039.36
Years: 10.01
Date Ratio
07/29/20141 for 5
VBIV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

VICL Split History
VIV Split History
VIVO Split History
VLRX Split History
VRTX Split History
VSCP Split History
VVUS Split History
WAT Split History
WGBS Split History
WOOF Split History

Also explore: VBIV shares outstanding history

Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
MicroSectors FANG+ Index 2X Leveraged ETNs due January 8, 2038 (FNGO)
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038 (FNGU)
Moleculin Biotech, Inc. (MBRX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

VBIV Insider Buying

VBIV Split History | www.SplitHistory.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.